Literature DB >> 29055153

Defining the actinic keratosis field: a literature review and discussion.

I Figueras Nart1, R Cerio2, T Dirschka3,4, B Dréno5, J T Lear6, G Pellacani7, K Peris8, A Ruiz de Casas9.   

Abstract

Despite the chronic and increasingly prevalent nature of actinic keratosis (AK) and existing evidence supporting assessment of the entire cancerization field during clinical management, a standardized definition of the AK field to aid in the understanding and characterization of the disease is lacking. The objective of this review was to present and appraise the available evidence describing the AK cancerization field, with the aim of determining a precise definition of the AK field in terms of its molecular (including genetic and immunological), histological and clinical characteristics. Eight European dermatologists collaborated to conduct a review and expert appraisal of articles detailing the characteristics of the AK field. Articles published in English before August 2016 were identified using PubMed and independently selected for further assessment according to predefined preliminary inclusion and exclusion criteria. In addition, a retrospective audit of patients with AK was performed to define the AK field in clinical terms. A total of 32 review articles and 47 original research articles provided evidence of sun-induced molecular (including genetic and immunological) and histological skin changes in the sun-exposed area affected by AK. However, the available literature was deemed insufficient to inform a clinical definition of the AK field. During the retrospective audit, visible signs of sun damage in 40 patients with AK were assessed. Telangiectasia, atrophy and pigmentation disorders emerged as 'reliable or very reliable' indicators of AK field based on expert opinion, whereas 'sand paper' was deemed a 'moderately reliable' indicator. This literature review has revealed a significant gap of evidence to inform a clinical definition of the AK field. Therefore, the authors instead propose a clinical definition of field cancerization based on the identification of visible signs of sun damage that are reliable indicators of field cancerization based on expert opinion.
© 2017 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2017        PMID: 29055153     DOI: 10.1111/jdv.14652

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  10 in total

1.  Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis.

Authors:  Norbert Kiss; Klára Farkas; Giulio Tosti; Federico De Gado; Beata Bergler-Czop; Gilda Fazia; Antonella Tammaro; Carmen Cantisani
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Updates on Treatment Approaches for Cutaneous Field Cancerization.

Authors:  Alisen Huang; Julie K Nguyen; Evan Austin; Andrew Mamalis; Jared Jagdeo
Journal:  Curr Dermatol Rep       Date:  2019-07-19

3.  Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.

Authors:  Amit Mittal; Mike Wang; Aurobind Vidyarthi; Diana Yanez; Gabriela Pizzurro; Durga Thakral; Erin Tracy; Oscar R Colegio
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

4.  Rosacea Flare - Up after Photodynamic Therapy (PDT) for Field Cancerization and a Review on Adverse Events with PDT in General.

Authors:  Uwe Wollina; Alena Bitel; Aleksandra Vojvodic; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2019-08-20

5.  Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.

Authors:  Ediléia Bagatin; Caroline Sousa Costa; Marco Alexandre Dias da Rocha; Fabíola Rosa Picosse; Cristhine Souza Leão Kamamoto; Rodrigo Pirmez; Mayra Ianhez; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2020-10-03       Impact factor: 1.896

Review 6.  Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma.

Authors:  Matthew L Hedberg; Corbett T Berry; Ata S Moshiri; Yan Xiang; Christopher J Yeh; Cem Attilasoy; Brian C Capell; John T Seykora
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

7.  AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients.

Authors:  Federica Veronese; Silvia Seoni; Vanessa Tarantino; Matteo Buttafava; Chiara Airoldi; Kristen M Meiburger; Elisa Zavattaro; Paola Savoia
Journal:  Front Med (Lausanne)       Date:  2022-09-07

8.  Actinic keratosis and surrounding skin exhibit changes in corneocyte surface topography and decreased levels of filaggrin degradation products.

Authors:  Anne J Keurentjes; Kornelis D de Witt; Ivone Jakasa; Lars Rüther; Patrick M J H Kemperman; Sanja Kezic; Christoph Riethmüller
Journal:  Exp Dermatol       Date:  2020-03-13       Impact factor: 3.960

9.  Non-Invasive Analysis of Actinic Keratosis before and after Topical Treatment Using a Cold Stimulation and Near-Infrared Spectroscopy.

Authors:  Silvia Seoni; Paola Savoia; Federica Veronese; Elisa Zavattaro; Vanessa Tarantino; Kristen M Meiburger
Journal:  Medicina (Kaunas)       Date:  2020-09-21       Impact factor: 2.430

Review 10.  A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.

Authors:  Robert Sinclair; Christopher Baker; Lynda Spelman; Madeleine Supranowicz; Beth MacMahon
Journal:  Australas J Dermatol       Date:  2020-08-25       Impact factor: 2.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.